| 17beta-estradiol | increases expression | ISO | RGD:1318572 | 6480464 | Estradiol results in increased expression of FBLN1 mRNA | CTD | PMID:23019147 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1318573 | 6480464 | Tetrachlorodibenzodioxin affects the expression of FBLN1 mRNA | CTD | PMID:21570461 |
| 3,4-methylenedioxymethamphetamine | increases expression | ISO | RGD:1318573 | 6480464 | N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of FBLN1 mRNA | CTD | PMID:20188158 |
| 4-phenylbutyric acid | increases expression | ISO | RGD:1318572 | 6480464 | 4-phenylbutyric acid results in increased expression of FBLN1 mRNA | CTD | PMID:14583596 |
| 5-azacytidine | increases expression | ISO | RGD:1318572 | 6480464 | Azacitidine results in increased expression of FBLN1 mRNA | CTD | PMID:21245298 |
| 5-fluorouracil | affects expression | ISO | RGD:1318572 | 6480464 | Fluorouracil affects the expression of FBLN1 mRNA | CTD | PMID:15205334 |
| 5-fluorouracil | increases expression | ISO | RGD:1318572 | 6480464 | Fluorouracil results in increased expression of FBLN1 mRNA | CTD | PMID:17039268 |
| 8-bromo-3',5'-cyclic AMP | increases expression | ISO | RGD:1318572 | 6480464 | 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of FBLN1 mRNA | CTD | PMID:15774544 |
| all-trans-retinoic acid | increases expression | ISO | RGD:1318573 | 6480464 | Tretinoin results in increased expression of FBLN1 mRNA | CTD | PMID:16604517 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:1318573 | 6480464 | Benzo(a)pyrene promotes the reaction [AHR protein binds to FBLN1 promoter] | CTD | PMID:19654925 |
| benzo[a]pyrene | decreases expression | ISO | RGD:1318573 | 6480464 | Benzo(a)pyrene results in decreased expression of FBLN1 mRNA | CTD | PMID:21569818 |
| cefaloridine | increases expression | EXP | | 6480464 | Cephaloridine results in increased expression of FBLN1 mRNA | CTD | PMID:18500788 |
| cobalt dichloride | decreases secretion | ISO | RGD:1318572 | 6480464 | cobaltous chloride results in decreased secretion of FBLN1 protein | CTD | PMID:22079246 |
| copper atom | multiple interactions | EXP | | 6480464 | [Copper deficiency co-treated with tetrathiomolybdate] results in decreased expression of FBLN1 mRNA; more ... | CTD | PMID:22276220 |
| copper(0) | multiple interactions | EXP | | 6480464 | [Copper deficiency co-treated with tetrathiomolybdate] results in decreased expression of FBLN1 mRNA; more ... | CTD | PMID:22276220 |
| copper(2+) sulfate | decreases expression | ISO | RGD:1318572 | 6480464 | Copper Sulfate results in decreased expression of FBLN1 mRNA | CTD | PMID:19549813 |
| cytarabine | decreases expression | ISO | RGD:1318572 | 6480464 | Cytarabine results in decreased expression of FBLN1 mRNA | CTD | PMID:21198554 |
| diuron | increases expression | EXP | | 6480464 | Diuron results in increased expression of FBLN1 mRNA | CTD | PMID:21551480 |
| doxorubicin | increases expression | ISO | RGD:1318573 | 6480464 | Doxorubicin results in increased expression of FBLN1 mRNA | CTD | PMID:15033991 |
| doxorubicin | affects expression | ISO | RGD:1318572 | 6480464 | Doxorubicin affects the expression of FBLN1 mRNA | CTD | PMID:15205334 |
| elemental selenium | increases expression | ISO | RGD:1318572 | 6480464 | Selenium results in increased expression of FBLN1 mRNA | CTD | PMID:19244175 |
| genistein | increases expression | ISO | RGD:1318572 | 6480464 | Genistein results in increased expression of FBLN1 mRNA | CTD | PMID:23019147 |
| hydrogen peroxide | affects expression | ISO | RGD:1318572 | 6480464 | Hydrogen Peroxide affects the expression of FBLN1 mRNA | CTD | PMID:20044591 |
| isotretinoin | increases expression | ISO | RGD:1318572 | 6480464 | Isotretinoin results in increased expression of FBLN1 mRNA | CTD | PMID:20436886 |
| medroxyprogesterone acetate | increases expression | ISO | RGD:1318572 | 6480464 | Medroxyprogesterone Acetate results in increased expression of FBLN1 mRNA; more ... | CTD | PMID:15774544 |
| medroxyprogesterone acetate | multiple interactions | ISO | RGD:1318572 | 6480464 | Mifepristone inhibits the reaction [Medroxyprogesterone Acetate results in increased expression of FBLN1 mRNA] | CTD | PMID:15774544 |
| menadione | affects expression | ISO | RGD:1318572 | 6480464 | Vitamin K 3 affects the expression of FBLN1 mRNA | CTD | PMID:20044591 |
| mifepristone | multiple interactions | ISO | RGD:1318572 | 6480464 | Mifepristone inhibits the reaction [Medroxyprogesterone Acetate results in increased expression of FBLN1 mRNA] | CTD | PMID:15774544 |
| mifepristone | decreases expression | ISO | RGD:1318572 | 6480464 | Mifepristone results in decreased expression of FBLN1 mRNA | CTD | PMID:17584828 |
| N-nitrosodiethylamine | increases expression | ISO | RGD:1318573 | 6480464 | Diethylnitrosamine results in increased expression of FBLN1 mRNA | CTD | PMID:17854601 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:1318573 | 6480464 | RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of FBLN1 mRNA] | CTD | PMID:17854601 |
| paracetamol | affects expression | ISO | RGD:1318573 | 6480464 | Acetaminophen affects the expression of FBLN1 mRNA | CTD | PMID:17562736 |
| paracetamol | increases expression | ISO | RGD:1318572 | 6480464 | Acetaminophen results in increased expression of FBLN1 mRNA | CTD | PMID:22230336 |
| phenobarbital | multiple interactions | ISO | RGD:1318573 | 6480464 | NR1I3 protein affects the reaction [Phenobarbital results in increased expression of FBLN1 mRNA] | CTD | PMID:19482888 |
| phenobarbital | increases expression | ISO | RGD:1318573 | 6480464 | Phenobarbital results in increased expression of FBLN1 mRNA | CTD | PMID:19482888 |
| pirinixic acid | decreases expression | ISO | RGD:1318573 | 6480464 | pirinixic acid results in decreased expression of FBLN1 mRNA | CTD | PMID:17426115 |
| progesterone | increases expression | ISO | RGD:1318572 | 6480464 | Progesterone results in increased expression of FBLN1 mRNA | CTD | PMID:15774544 |
| selenium atom | increases expression | ISO | RGD:1318572 | 6480464 | Selenium results in increased expression of FBLN1 mRNA | CTD | PMID:19244175 |
| sirolimus | increases expression | EXP | | 6480464 | Sirolimus results in increased expression of FBLN1 mRNA | CTD | PMID:21865292 |
| tacrolimus hydrate | increases expression | EXP | | 6480464 | Tacrolimus results in increased expression of FBLN1 mRNA | CTD | PMID:21865292 |
| tert-butyl hydroperoxide | decreases expression | ISO | RGD:1318572 | 6480464 | tert-Butylhydroperoxide results in decreased expression of FBLN1 mRNA | CTD | PMID:15336504 |
| tetrathiomolybdate(2-) | multiple interactions | EXP | | 6480464 | [Copper deficiency co-treated with tetrathiomolybdate] results in decreased expression of FBLN1 mRNA; more ... | CTD | PMID:22276220 |
| trimellitic anhydride | decreases expression | ISO | RGD:1318573 | 6480464 | trimellitic anhydride results in decreased expression of FBLN1 mRNA | CTD | PMID:19042947 |